Citadel Advisors’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $605K | Sell |
220,700
-131,000
| -37% | -$415K | ﹤0.01% | 8833 |
|
|
2025
Q4 | $1.3M | Buy |
351,700
+266,100
| +311% | +$860K | ﹤0.01% | 6831 |
|
|
2025
Q3 | $227K | Buy |
85,600
+57,700
| +207% | +$112K | ﹤0.01% | 10987 |
|
|
2025
Q2 | $27.5K | Sell |
27,900
-72,900
| -72% | -$73K | ﹤0.01% | 12015 |
|
|
2025
Q1 | $145K | Buy |
100,800
+63,100
| +167% | +$116K | ﹤0.01% | 10928 |
|
|
2024
Q4 | $82.9K | Sell |
37,700
-35,000
| -48% | -$81.7K | ﹤0.01% | 11744 |
|
|
2024
Q3 | $120K | Buy |
72,700
+31,600
| +77% | +$63.8K | ﹤0.01% | 10882 |
|
|
2024
Q2 | $91.2K | Sell |
41,100
-106,400
| -72% | -$250K | ﹤0.01% | 11047 |
|
|
2024
Q1 | $395K | Buy |
147,500
+85,300
| +137% | +$207K | ﹤0.01% | 8880 |
|
|
2023
Q4 | $186K | Buy |
62,200
+8,300
| +15% | +$10.8K | ﹤0.01% | 10057 |
|
|
2023
Q3 | $52.8K | Sell |
53,900
-104,500
| -66% | -$151K | ﹤0.01% | 11698 |
|
|
2023
Q2 | $220K | Sell |
158,400
-27,200
| -15% | -$38K | ﹤0.01% | 9676 |
|
|
2023
Q1 | $295K | Sell |
185,600
-226,500
| -55% | -$1.17M | ﹤0.01% | 9409 |
|
|
2022
Q4 | $2.57M | Buy |
412,100
+202,500
| +97% | +$1.45M | ﹤0.01% | 5019 |
|
|
2022
Q3 | $1.4M | Buy |
209,600
+51,900
| +33% | +$356K | ﹤0.01% | 6287 |
|
|
2022
Q2 | $1M | Buy |
157,700
+30,700
| +24% | +$174K | ﹤0.01% | 7001 |
|
|
2022
Q1 | $589K | Sell |
127,000
-39,000
| -23% | -$167K | ﹤0.01% | 8994 |
|
|
2021
Q4 | $830K | Buy |
166,000
+89,000
| +116% | +$713K | ﹤0.01% | 8396 |
|
|
2021
Q3 | $928K | Buy |
77,000
+49,700
| +182% | +$724K | ﹤0.01% | 8341 |
|
|
2021
Q2 | $577K | Sell |
27,300
-26,400
| -49% | -$636K | ﹤0.01% | 9731 |
|
|
2021
Q1 | $1.51M | Sell |
53,700
-42,100
| -44% | -$1.24M | ﹤0.01% | 7090 |
|
|
2020
Q4 | $2.49M | Sell |
95,800
-3,100
| -3% | -$92.9K | ﹤0.01% | 4901 |
|
|
2020
Q3 | $3.68M | Buy |
98,900
+12,800
| +15% | +$507K | ﹤0.01% | 3629 |
|
|
2020
Q2 | $4.42M | Buy |
86,100
+48,300
| +128% | +$2.02M | ﹤0.01% | 3254 |
|
|
2020
Q1 | $1.19M | Sell |
37,800
-26,700
| -41% | -$1.41M | ﹤0.01% | 5015 |
|
|
2019
Q4 | $3.85M | Buy |
64,500
+11,800
| +22% | +$531K | ﹤0.01% | 3440 |
|
|
2019
Q3 | $1.93M | Sell |
52,700
-36,900
| -41% | -$1.46M | ﹤0.01% | 4528 |
|
|
2019
Q2 | $4.17M | Buy |
89,600
+7,700
| +9% | +$362K | ﹤0.01% | 3369 |
|
|
2019
Q1 | $3.29M | Buy |
81,900
+42,500
| +108% | +$1.91M | ﹤0.01% | 3605 |
|
|
2018
Q4 | $1.81M | Sell |
39,400
-12,800
| -25% | -$617K | ﹤0.01% | 4298 |
|
|
2018
Q3 | $2.32M | Sell |
52,200
-20,700
| -28% | -$950K | ﹤0.01% | 4163 |
|
|
2018
Q2 | $2.86M | Buy |
72,900
+25,700
| +54% | +$1.3M | ﹤0.01% | 3556 |
|
|
2018
Q1 | $3.41M | Buy |
47,200
+10,300
| +28% | +$756K | ﹤0.01% | 2960 |
|
|
2017
Q4 | $2.43M | Buy |
36,900
+24,200
| +191% | +$1.3M | ﹤0.01% | 3361 |
|
|
2017
Q3 | $637K | Sell |
12,700
-15,500
| -55% | -$747K | ﹤0.01% | 4974 |
|
|
2017
Q2 | $1.3M | Sell |
28,200
-15,600
| -36% | -$574K | ﹤0.01% | 3719 |
|
|
2017
Q1 | $1.55M | Buy |
+43,800
| New | +$1M | ﹤0.01% | 3387 |
|
|
2016
Q4 | – | Sell |
-18,500
| Closed | -$256K | – | 7389 |
|
|
2016
Q3 | $256K | Sell |
18,500
-1,900
| -9% | -$21.5K | ﹤0.01% | 5936 |
|
|
2016
Q2 | $202K | Buy |
20,400
+4,200
| +26% | +$69.6K | ﹤0.01% | 5818 |
|
|
2016
Q1 | $274K | Buy |
16,200
+3,600
| +29% | +$57.9K | ﹤0.01% | 5212 |
|
|
2015
Q4 | $280K | Sell |
12,600
-17,100
| -58% | -$431K | ﹤0.01% | 5319 |
|
|
2015
Q3 | $701K | Buy |
29,700
+16,800
| +130% | +$1.05M | ﹤0.01% | 4300 |
|
|
2015
Q2 | $1.05M | Sell |
12,900
-11,200
| -46% | -$1.1M | ﹤0.01% | 3902 |
|
|
2015
Q1 | $2.23M | Buy |
+24,100
| New | +$1.56M | ﹤0.01% | 2926 |
|
Other funds holding ESPR
WA
TSC
O
VCM